Overview
- 78 inspections across 74 sites are on record.
- 265 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-13.
At a glance
Inspections
78
Sites
74
Observations
265
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pyramid Laboratories, Inc. | 13 Feb 2026 | Human Drugs | View 483 → |
| North American Science Associates, LLC | 24 Jul 2025 | Human Drugs | View 483 → |
| Forma Life Sciences, Inc | 23 Feb 2024 | Human Drugs | View 483 → |
| Abbott Vascular Inc | 27 Oct 2023 | Medical Devices & Rad Health | |
| Clinical Resolution Laboratory, Inc. | 29 Sep 2023 | Human Drugs | View 483 → |
Sites inspected
Pyramid Laboratories, Inc.Costa Mesa, United States1 insp.
North American Science Associates, LLCIrvine, United States1 insp.
Forma Life Sciences, IncIrvine, United States1 insp.
Abbott Vascular IncTemecula, United States1 insp.
Clinical Resolution Laboratory, Inc.Brea, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ka L Wong5 shared
Grace P Santos4 shared
Walden H Lee3 shared
Sean P Desbrow3 shared
Joseph C Yen3 shared
Sangeeta M Khurana2 shared
Claudia M Perez-Kasmarski2 shared
Gavin T Cua2 shared
Joel D Hustedt2 shared
Amir Alavi2 shared
Full investigator report
Get the verbatim findings behind Bryan A Galvez's 265 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site